• WHO’s new guideline offers a robust framework for tobacco cessation, targeting over 750 million users wishing to quit.

• The recommendations encompass all forms of tobacco, including cigarettes, waterpipes, and smokeless products.

• Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, highlights the guideline’s potential to reduce the global burden of tobacco-related diseases.

• The guidelines emphasize that effective cessation therapies combining pharmacotherapy (varenicline, NRT, bupropion, and cytisine) with behavioral support significantly improve success rates.

• WHO advocates for accessible treatments, especially in low- and middle-income countries, and prequalified Kenvue’s nicotine gum and patch in 2024.

• It also includes digital tools like text messaging and apps that complement traditional counseling methods.

• WHO urges healthcare providers and policymakers to adopt these guidelines to enhance global tobacco cessation efforts.

Click here to read more.